Andrew A. Hindman

2019

In 2019, Andrew A. Hindman earned a total compensation of $3.8M as Senior Vice President and Chief Financial Officer at Theravance Biopharma.

Compensation breakdown

Bonus$175,000
Non-Equity Incentive Plan$216,000
Option Awards$2,204,956
Salary$315,000
Stock Awards$847,000
Total$3,757,956

Hindman received $2.2M in option awards, accounting for 59% of the total pay in 2019.

Hindman also received $175K in bonus, $216K in non-equity incentive plan, $315K in salary and $847K in stock awards.

Rankings

In 2019, Andrew A. Hindman's compensation ranked 3,207th out of 13,971 executives tracked by ExecPay. In other words, Hindman earned more than 77.0% of executives.

ClassificationRankingPercentile
All
3,207
out of 13,971
77th
Division
Manufacturing
1,160
out of 5,701
80th
Major group
Chemicals And Allied Products
395
out of 2,200
82nd
Industry group
Drugs
325
out of 1,886
83rd
Industry
Pharmaceutical Preparations
241
out of 1,398
83rd

Pay ratio

Andrew A. Hindman's Pay$3,757,956
Median Employee's Pay$219,765
Pay Ratio

17

to 1

In 2019, the annual total compensation of Andrew A. Hindman was $3,757,956.

The annual total compensation of the median employee at Theravance Biopharma was $219,765.

The ratio of Andrew A. Hindman's pay to the pay of median employee was therefore 17 to one.

Source: SEC filing on March 24, 2020.

Hindman's colleagues

We found five more compensation records of executives who worked with Andrew A. Hindman at Theravance Biopharma in 2019.

2019

Rick Winningham

Theravance Biopharma

Chief Executive Officer

2019

Bradford Shafer

Theravance Biopharma

General Counsel

2019

Brett Haumann

Theravance Biopharma

Chief Medical Officer

2019

Frank Pasqualone

Theravance Biopharma

Senior Vice President and Chief Commercial Operations Officer

2019

Renee Gala

Theravance Biopharma

Chief Financial Officer

News

In-depth

You may also like